arrow
Back
V

Vladimı́r Tesař

charles university

79H-index
878Paper Count
4.0WCitation Count
Published Papers 148
Publication Date
Towards a proteomic plasma biomarker panel for diagnosing vasculitis remission
err2026-07-21
err0
errOAAI
errUwe Jerke; Marieluise Kirchner; Theda UP Bartolomaeus; Lovis Kling; Vojtech Kratky; Zdenka Hruskova; Vladimir Tesar; Kai-Uwe Eckardt; Adrian Schreiber; Sofia Forslund; Philipp Mertins; Ralph Kettritz
errShare
errSave
Negative impact of very mild volume overload on the heart function in patients on chronic hemodialysis
err2026-03-04
err0
errOAAI
errKristyna Michalickova; Jan Malik; Anna Valerianova; Zdenka Hruskova; Vladimira Bednarova; Frantisek Lopot; Kristina Buryskova Salajova; Zuzana Hladinova; Tereza Vychodilova; Satu Sinikka Pesickova; Katarina Rocinova; Monika Tothova; Barbora Szonowska; Marketa Kratochvilova; Lucie Kaiserova; Simona Janakova; Vladimir Tesar
errShare
errSave
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup
err2025-12-08
err0
errOAAI
errAmanda DeMauro Renaghan; Marlies Ostermann; Claudio Ronco; Karen Ballen; Laura Cosmai; Roberta Fenoglio; Matteo Floris; Lui G. Forni; Douglas E. Gladstone; Ilya G. Glezerman; Stuart L. Goldstein; Shruti Gupta; Sandra M. Herrmann; Edgar A. Jaimes; Kenar D. Jhaveri; Sabine Karam; Abhijat Kitchlu; Heather J. Landau; Sheron Latcha; David E. Leaf; Paolo Lentini; Jolanta Małyszko; Glen Markowitz; Naoka Murakami; Antonello Pani; Mark A. Perazella; Arash Rashidi; Dario Roccatello; Elad Sharon; Ben Sprangers; Vladimír Tesař; Verônica Torres; Rimda Wanchoo; Andrew Whitman; Biruh T. Workeneh; Diana Zepeda-Orozco; Mitchell H. Rosner
errShare
errSave
A Pooled Analysis of Sex Differences in Lupus Nephritis
err2025-11-07
err0
errOAAI
errKristina K. Nasr; Ryan B. Coopergard; Sisi Ma; Tak Mao Chan; Manish Rathi; Frederic A. Houssiau; Zdenka Hruskova; Vivekanand Jha; Neil Solomons; Stephen M. Korbet; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Vladimir Tesar; Matt Truman; Juan Mejia-Vilet; Melissa R. West; Brad H. Rovin; Patrick H. Nachman
errShare
errSave
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
err2025-11-01
err5
PREAI
errLafayette, Richard; Barbour, Sean J.; Brenner, Robert M.; Campbell, Kirk N.; Doan, Tom; Eren, Necmi; Floege, Jurgen; Jha, Vivekanand; Kim, Beom Seok; Liew, Adrian; Maes, Bart; Pal, Atanu; Pecoits-Filho, Roberto; Phoon, Richard K. S.; Rizk, Dana V.; Suzuki, Hitoshi; Tesar, Vladimir; Trimarchi, Hernan; Wei, Xuelian; Zhang, Hong; Barratt, Jonathan
errShare
errSave
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
err2025-11-01
err4
PREAI
errPerkovic, Vlado; Trimarchi, Hernan; Tesar, Vladimir; Lafayette, Richard; Wong, Muh Geot; Barratt, Jonathan; Suzuki, Yusuke; Liew, Adrian; Zhang, Hong; Carroll, Kevin; Jha, Vivekanand; Quevedo, Alejandra; Han, Seung Hyeok; Praga, Manuel; Chacko, Bobby; Sahay, Manisha; Cheung, Chee Kay; Kooienga, Laura; Walsh, Michael; Xia, Jing; Fajardo, Cecile; Shah, Lokesh; Hafkin, Jeffrey; Rizk, Dana V.
errShare
errSave
Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Lafayette, Richard; Reich, Heather; Kristensen, Jens; Jones, Russell; Floege, Jurgen; Tesar, Vladimir; Trimarchi, Hernan; Zhang, Hong; Rovin, Brad
errShare
errSave
Sustainability and depth of UPCR reduction in patients with primary IgAN treated with nefecon: a secondary analysis of the Phase 3 NefIgArd trial
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Reich, Heather; Kristensen, Jens; Jones, Russell; Floege, Jurgen; Tesar, Vladimir; Trimarchi, Hernan; Zhang, Hong; Rovin, Brad; Lafayette, Richard
errShare
errSave
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial
err2025-10-01
err0
errOAAI
errVlado Perkovic; Jonathan Barratt; Richard Lafayette; Adrian Liew; Yusuke Suzuki; Kevin Carroll; Chee Kay Cheung; Vladimír Tesař; Hernán Trimarchi; Muh Geot Wong; Hong Zhang; Jing Xia; Cecile Fajardo; Lokesh Shah; Jeffrey Hafkin; Dana V. Rizk
errShare
errSave
Effects of sparsentan after maximized angiotensin receptor blocker (ARB) treatment in patients with IgA nephropathy (IgAN) in the PROTECT trial
err2025-10-01
err0
errOAAI
errFloege, Jurgen; Rizk, Dana; Preciado, Priscila; Rovin, Brad; Moody, Stephanie; Geletka, Rob; Mercer, Alex; Hendry, Bruce; Komers, Radko; Tesar, Vladimir
errShare
errSave
Nefecon provides kidney benefit irrespective of time since diagnosis in patients with IgAN: a subanalysis of the NefIgArd study
err2025-10-01
err0
errOAAI
errLafayette, Richard; Barratt, Jonathan; Reich, Heather; Kristensen, Jens; Jones, Russell; Floege, Jurgen; Tesar, Vladimir; Trimarchi, Hernan; Zhang, Hong; Rovin, Brad
errShare
errSave
ORIGIN 2b: changes in Gd-IgA1 and eGFR after discontinuation of atacicept treatment in IgA nephropathy
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Barbour, Sean; Brenner, Robert; Eren, Necmi; Floege, Jurgen; Jha, Vivekanand; Kim, Sung Gyun; Maes, Bart; Phoon, Richard; Singh, Harmeet; Tesar, Vladimir; Lafayette, Richard
errShare
errSave
Patients with focal segmental glomerulosclerosis (FSGS) achieved low proteinuria targets earlier and more often with sparsentan (SPAR) vs irbesartan (IRB) in DUPLEX
err2025-10-01
err0
errOAAI
errTesar, Vladimir; Trimarchi, Hernan; Tumlin, James; Kooienga, Laura; Komers, Radko; Inrig, Jula; Murphy, Edward; Garcia, Eva Rodriguez
errShare
errSave
Origin 3 study design: a global, randomized, controlled, Phase 3 study of atacicept in IgA nephropathy
err2025-10-01
err0
PREAI
errLafayette, Richard; Maes, Bart; Brenner, Robert; Khawaja, Zeeshan; Floege, Jurgen; Jha, Vivekanand; Tesar, Vladimir; Zhang, Hong; Barbour, Sean; Suzuki, Hitoshi; Trimarchi, Hernan; Barratt, Jonathan
errShare
errSave
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial
err2025-03-01
err1
errOAAI
errOdler, Balazs; Riedl, Regina; Geetha, Duvuru; Szpirt, Wladimir M.; Hawley, Carmel; Uchida, Lisa; Wallace, Zachary S.; Walters, Giles; Muso, Eri; Tesar, Vladimir; Pusey, Charles D.; Little, Mark A.; Merkel, Peter A.; Walsh, Michael; Jayne, David R. W.
errShare
errSave
Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implications
err2025-02-23
err0
errOAAI
errSalajova, Kristina Buryskova; Malik, Jan; Kaiserova, Lucie; Hladinova, Zuzana; Hruskova, Zdenka; Janakova, Simona; Tesar, Vladimir; Pesickova, Satu Sinikka; Michalickova, Kristyna; Rocinova, Katarina; Szonowska, Barbora; Valerianova, Anna
errShare
errSave
Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular Diseases
err2025-02-06
err0
errOAAI
errVoroneanu, Luminita; Covic, Andreea; Tesar, Vladimir; Kanbay, Mehmet; Covic, Adrian
errShare
errSave
Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis
err2025-02-01
err0
errOAAI
errTrejo, Maria A. C. Wester; Sadeghi, Maryam; Singh, Shivam; Mahmoodian, Naghmeh; Sharifli, Samir; Hruskova, Zdenka; Tesar, Vladimir; Puechal, Xavier; Bruijn, Jan Anthonie; Goebel, Georg; Bajema, Ingeborg M.; Kronbichler, Andreas
errShare
errSave
errShare
errSave